Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension - Meng, Juan; Xiao, Guohui; Zhang, Juanjuan; He, Xing; Ou, Min; Bi, Jing; Yang, Rongqing; Di, Wencheng; Wang, Zhaoqin; Li, Zigang; Gao, Hong; Liu, Lei; et al. (Emerging microbes & infections, 2020)
Keywords: Aged; Angiotensin II Type 1 Receptor Blockers - therapeutic use; angiotensin II type1 receptor blockers; angiotensin-converting enzyme inhibitors; Angiotensin-Converting Enzyme Inhibitors - therapeutic use; Antihypertensive Agents - therapeutic use; Betacoronavirus; C-Reactive Protein - analysis; CD3 Complex; CD8-Positive T-Lymphocytes - cytology; China; Clinical outcomes; Coronavirus Infections - complications; Coronavirus Infections - drug therapy; Coronaviruses; COVID-19; Diuretics; Female; Humans; Hypertension; Hypertension - complications; Hypertension - drug therapy; Hypertension - virology; Interleukin-6 - blood; Letter; Male; Middle Aged; Pandemics; Pneumonia, Viral - complications; Pneumonia, Viral - drug therapy; Renin-Angiotensin System; Retrospective Studies; SARS-CoV-2; Treatment Outcome; Viral Load; China; COVID-19; angiotensin-converting enzyme inhibitors; angiotensin II type1 receptor blockers; Renin-angiotensin system; hypertension